| Literature DB >> 33980966 |
Emanuela Locci1, Alberto Chighine2, Antonio Noto2, Giulio Ferino2, Alfonso Baldi3, Dimitrios Varvarousis4, Theodoros Xanthos5, Fabio De-Giorgio6,7, Matteo Stocchero8, Ernesto d'Aloja2.
Abstract
The diagnosis of mechanical asphyxia remains one of the most difficult issues in forensic pathology. Asphyxia ultimately results in cardiac arrest (CA) and, as there are no specific markers, the differential diagnosis of primitive CA and CA secondary to asphyxiation relies on circumstantial details and on the pathologist experience, lacking objective evidence. Histological examination is currently considered the gold standard for CA post-mortem diagnosis. Here we present the comparative results of histopathology versus those previously obtained by 1H nuclear magnetic resonance (NMR) metabolomics in a swine model, originally designed for clinical purposes, exposed to two different CA causes, namely ventricular fibrillation and asphyxia. While heart and brain microscopical analysis could identify the damage induced by CA without providing any additional information on the CA cause, metabolomics allowed the identification of clearly different profiles between the two groups and showed major differences between asphyxiated animals with good and poor outcomes. Minute-by-minute plasma sampling allowed to associate these modifications to the pre-arrest asphyxial phase showing a clear correlation to the cellular effect of mechanical asphyxia reproduced in the experiment. The results suggest that metabolomics provides additional evidence beyond that obtained by histology and immunohistochemistry in the differential diagnosis of CA.Entities:
Year: 2021 PMID: 33980966 PMCID: PMC8115104 DOI: 10.1038/s41598-021-89570-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical and experimental parameters of the studied groups.
| ACA group | VFCA group | |||||||
|---|---|---|---|---|---|---|---|---|
| Animal | Mechanical asphyxia time prior to CA (minutes) | Group D vs ND | CPR time (minutes) | NS 24 h | Animal | Group D vs ND | CPR time (minutes) | NS 24 h |
| ACA1 | 4 | ND | 4 | 70 | VFCA1 | ND | 2 | 100 |
| ACA2 | 7 | ND | 2 | 100 | VFCA2 | ND | 8 | 100 |
| ACA3 | 4 | ND | 2 | 100 | VFCA3 | ND | 4 | 100 |
| ACA4 | 9 | D | 10 | – | VFCA4 | D | 20 | – |
| ACA5 | 10 | D | 6 | 50 | VFCA5 | ND | 4 | 100 |
| ACA6 | 8 | D | 14 | – | VFCA6 | ND | 4 | 100 |
| ACA7 | 4 | ND | 2 | 100 | VFCA7 | ND | 2 | 100 |
| ACA8 | 8 | ND | 2 | 100 | VFCA8 | ND | 4 | 100 |
| ACA9 | 9 | D | 9 | – | VFCA9 | ND | 6 | 100 |
| ACA10 | 5 | ND | 6 | 80 | VFCA10 | D | 16 | – |
D = damaged animals; ND = no-damaged animals; CPR = Cardio Pulmonary Resuscitation; NS = neurological score.
Results of histopathological and immunohistochemical analyses of brain and heart samples, with partial and global arbitrary scores.
| Animal | Brain | Total Score | Heart | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Histology | IHC | Histology | IHC | |||||||||||
| MI | Tu | Ty | De | S100B | GFAP | Score | Score | MI | Tu | MA | TnC | D | ||
| ACA1 | 0 | 1 | 0 | 0 | 1 | 1 | 3 | 7 | 4 | 0 | 1 | 1 | 1 | 1 |
| ACA2 | 0 | 1 | 0 | 0 | 1 | 1 | 3 | 7 | 4 | 0 | 1 | 1 | 1 | 1 |
| ACA3 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 5 | 3 | 0 | 0 | 1 | 1 | 1 |
| ACA7 | 0 | 1 | 0 | 0 | 1 | 2 | 4 | 10 | 6 | 0 | 1 | 2 | 1 | 2 |
| ACA8 | 0 | 1 | 0 | 0 | 1 | 1 | 3 | 8 | 5 | 0 | 1 | 2 | 1 | 1 |
| VFCA1 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 5 | 3 | 0 | 0 | 1 | 1 | 1 |
| VFCA2 | 0 | 1 | 0 | 1 | 2 | 1 | 5 | 13 | 8 | 0 | 2 | 2 | 2 | 2 |
| VFCA3 | 0 | 1 | 0 | 0 | 1 | 1 | 3 | 7 | 4 | 0 | 1 | 1 | 1 | 1 |
| VFCA5 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 6 | 4 | 0 | 1 | 1 | 1 | 1 |
| VFCA6 | 0 | 1 | 0 | 0 | 2 | 1 | 4 | 8 | 4 | 0 | 1 | 1 | 1 | 1 |
| VFCA7 | 0 | 0 | 0 | 0 | 2 | 1 | 3 | 7 | 4 | 0 | 1 | 1 | 1 | 1 |
| VFCA8 | 0 | 0 | 0 | 0 | 2 | 1 | 3 | 6 | 3 | 0 | 1 | 1 | 1 | 0 |
| VFCA9 | 0 | 1 | 0 | 0 | 3 | 2 | 6 | 12 | 6 | 0 | 1 | 2 | 1 | 2 |
IHC = Immunohistochemistry; MI = Micro-Infarction; Tu = TUNEL; Ty = Tygrolisis; De = Demyelination; MA = Morphological alterations; GFAP = Glial Fibrillary Acid Pro; TnC = C-Troponin; D = Desmin.
Assigned scores: MI, Ty, De: 0 = absent, 1 = present; MA, 0 = absent, 1 = mild, 2 = moderate, 3 = severe; Tu: 0 = absent, 1 = up to 2%, 2 = up to 5%, 3 = more than 5%; S100B, GFAP, D, TnC: 0 = absent, 1 = mild, 2 = moderate, 3 = severe.
Figure 1PCA score plot of ACA and VFCA plasma samples (a) at baseline (A = 3, Par, R2 = 0.81, Q2 = 0.59), (b) at baseline vs. the 5th minute of untreated CA (A = 3, Par, R2 = 0.83, Q2 = 0.68), and (c) at the 5th minute of untreated CA (A = 3, Par, R2 = 0.86, Q2 = 0.67). ACA samples are represented by open circles at baseline and black circles at arrest. VFCA samples are represented by open triangles at baseline and black triangles at arrest.
Figure 2PCA score plot of ACA plasma samples collected at (a) baseline vs. the first 4 min of the pre-arrest phase (A = 3, Par, R2 = 0.84, Q2 = 0.73), (b) baseline vs. all pre-arrest samples (A = 3, Par, R2 = 0.82, Q2 = 0.71). Samples are represented by open circles at baseline, black squares at pre-arrest ≤ 4 min, and open squares at pre-arrest ≥ 5 min. Labels correspond to the animal number.
Figure 3PCA score plot of ACA plasma samples collected at baseline vs. the pre-arrest samples from the 5th minute (A = 3, Par, R2 = 0.83, Q2 = 0.67). Samples are represented by open circles at baseline, black squares at pre-arrest for ND animals, and open squares at pre-arrest for D animals. Labels correspond to the animal number.
Figure 4Modification of the fold change in concentration with respect to baseline values of the modified metabolites over the asphyxial period shown for each animal.